The U.S. Food and Drug Administration (FDA) has issued a Class I recall for 400 boxes of organic blueberries from Alma Pak International LLC, Georgia. This voluntary recall was initially issued on June 9, with the FDA's classification following on July 1.
A Class I risk classification indicates a scenario where using or being exposed to a product may lead to serious adverse health effects or death. Listeria monocytogenes contamination prompted the recall, as this bacterium can cause listeriosis, manifesting in symptoms from mild to severe. The FDA notes that less severe symptoms include fever, muscle aches, nausea, vomiting, and diarrhea, typically lasting between one and three days. However, severe infections can involve headaches, stiff neck, confusion, and loss of balance. Newborns, older adults, and those with compromised immune systems are particularly vulnerable.
The recalled products can be identified by Lot numbers: 13325 G1060 / 13325 G1096, with the affected blueberries entirely recovered before retail distribution, posing no public health risk. Alma Pak International, collaborating with the FDA, the Georgia Department of Agriculture, and an independent food safety consultant, has implemented enhanced food safety measures. The company has conducted intensified vector sampling as part of its 'seek and destroy' approach, confirming no Listeria monocytogenes presence in subsequent samples.
In statements to Newsweek, Alma Pak International emphasized its dedication to food safety and maintaining trust. Haley F. Oliver from Purdue University noted that Listeria monocytogenes are common in the environment, with immunocompromised individuals at higher risk of infection from contaminated food. Mary O'Riordan from the University of Michigan Medical School highlighted that Listeria can grow at refrigerated temperatures and often isn't diagnosed immediately, as early symptoms resemble other foodborne illnesses. The FDA has identified pregnant women, their newborns, adults over 65, and immunocompromised individuals as high-risk groups for listeriosis.
The recall remains ongoing. The FDA advises those suspecting a listeriosis infection to seek medical attention promptly.
Source: Newsweek